Selected article for: "AH tear and VORI gel subconjunctival injection"
Title: 2017 ACVIM Forum Research Abstract Program
  • Document date: 2017_6_15
    • ID: ri2w5iby_805
    Snippet: Subconjunctival injection of VORI-GEL is safe. In normal horses, low AH and tear concentrations are likely due to intact ocular barriers and high drug lipophilicity. There is sustained release of therapeutic concentrations of voriconazole from the VORI-GEL to the anterior segment tissues for at least 2 days following injection. A diagnosis of inflammatory airway disease (IAD) is commonly based on abnormal bronchoalveolar lavage fluid (BALF) cytol.....
    Document: Subconjunctival injection of VORI-GEL is safe. In normal horses, low AH and tear concentrations are likely due to intact ocular barriers and high drug lipophilicity. There is sustained release of therapeutic concentrations of voriconazole from the VORI-GEL to the anterior segment tissues for at least 2 days following injection. A diagnosis of inflammatory airway disease (IAD) is commonly based on abnormal bronchoalveolar lavage fluid (BALF) cytology or airway hyperreactivity (AHR) in horses with poor performance or chronic cough. Our study purpose was to determine whether two modalities of non-invasive lung function testing (FOM-forced oscillatory mechanics vs. RIP-Respiratory Inductive Plethysmography) establish the same clinical diagnosis of AHR, using histamine bronchoprovocation. AHR was defined by the histamine dose needed to double FOM baseline resistance, or to achieve a 35% increase in RIP delta flow.

    Search related documents:
    Co phrase search for related documents
    • AHR airway hyperreactivity and BALF cytology: 1
    • AHR airway hyperreactivity and bronchoalveolar lavage fluid: 1
    • AHR airway hyperreactivity and IAD inflammatory airway disease: 1
    • AHR airway hyperreactivity and inflammatory airway: 1
    • AHR airway hyperreactivity and inflammatory airway disease: 1
    • AHR airway hyperreactivity and lavage fluid: 1, 2
    • airway hyperreactivity and BALF cytology: 1
    • airway hyperreactivity and bronchoalveolar lavage fluid: 1, 2